PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Premera Blue CrossCommercial · Prior Auth · Medical Policy · WA, AK · Allergy & Immunology, Rheumatology, Gastroenterology +13 moreHigh impact

Medical Policy and Coding Updates - March 2025

Effective date
Not stated in the notice
Identified
Jun 16, 2026

Summary

Premera's March 2025 update changes adalimumab and pegfilgrastim preferences, with Humira (AbbVie) moving from a preferred to a non-preferred adalimumab product effective July 1, 2025. It also adds new Parkinson's disease and seizure drug policies effective March 1, 2025, and lists code 92972 as now requiring review for investigational, while several SARS-CoV-2 serology codes and code 25448 no longer require review.

Get alerts when payers change rules like this one

We check Premera Blue Cross and other payers every day and email you when a change matches your specialty and state.

Get Premera Blue Cross alertsPolicy Monitoring is free. No card required.

What to do

Action · 5 steps
01Already effective July 1, 2025, June 6, 2025, May 6, 2025, April 20, 2025, April 6, 2025, March 5, 2025 and March 1, 2025, so check current applicability before acting on these past dates.
02Billing team: Humira (AbbVie) (adalimumab) [NDCs starting with 00074] changed from a preferred to a non-preferred adalimumab product, effective July 1, 2025.
03Billing team: Udenyca (pegfilgrastim-cbqv) and Udenyca Onbody moved from second-line to first-line therapy for individuals younger than 18 years of age, and from third-line to second-line therapy for individuals aged 18 years and older; Nyvepria moved from first-line to second-line for individuals younger than 18, and from second-line to third-line for individuals aged 18 years and older, effective July 1, 2025.
04Billing team: code 92972 now requires review for investigational, effective March 5, 2025.
05Billing team: codes 25448, 0224U, 86328, 86413 and 86769 no longer require review, effective March 1, 2025, and the SARS-CoV-2 Serology (Antibody) Testing policy 2.04.518 was archived.

Codes mentioned

9297225448863288641386769

Original notice

Medical Policy and Coding Updates - March 2025
premera.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account